These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15456258)

  • 1. Inhibition of isoprene biosynthesis pathway enzymes by phosphonates, bisphosphonates, and diphosphates.
    Cheng F; Oldfield E
    J Med Chem; 2004 Oct; 47(21):5149-58. PubMed ID: 15456258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5-phosphate reductoisomerase complexes.
    Yajima S; Hara K; Sanders JM; Yin F; Ohsawa K; Wiesner J; Jomaa H; Oldfield E
    J Am Chem Soc; 2004 Sep; 126(35):10824-5. PubMed ID: 15339150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
    Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E
    J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase.
    Silber K; Heidler P; Kurz T; Klebe G
    J Med Chem; 2005 May; 48(10):3547-63. PubMed ID: 15887963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
    Sanders JM; Ghosh S; Chan JM; Meints G; Wang H; Raker AM; Song Y; Colantino A; Burzynska A; Kafarski P; Morita CT; Oldfield E
    J Med Chem; 2004 Jan; 47(2):375-84. PubMed ID: 14711309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.
    Mac Sweeney A; Lange R; Fernandes RP; Schulz H; Dale GE; Douangamath A; Proteau PJ; Oefner C
    J Mol Biol; 2005 Jan; 345(1):115-27. PubMed ID: 15567415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis.
    Martin MB; Arnold W; Heath HT; Urbina JA; Oldfield E
    Biochem Biophys Res Commun; 1999 Oct; 263(3):754-8. PubMed ID: 10512752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1.9 A resolution structure of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a potential drug target.
    Henriksson LM; Björkelid C; Mowbray SL; Unge T
    Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):807-13. PubMed ID: 16790937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase from Shewanella oneidensis at 1.6 A: identification of farnesyl pyrophosphate trapped in a hydrophobic cavity.
    Ni S; Robinson H; Marsing GC; Bussiere DE; Kennedy MA
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1949-57. PubMed ID: 15502301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprenoid biosynthesis via the MEP pathway. Synthesis of (3,4)-3,4-dihydroxy-5-oxohexylphosphonic acid, an isosteric analogue of 1-deoxy-D-xylulose 5-phosphate, the substrate of the 1-deoxy-D-xylulose 5-phosphate reducto-isomerase.
    Meyer O; Grosdemange-Billiard C; Tritsch D; Rohmer M
    Org Biomol Chem; 2003 Dec; 1(24):4367-72. PubMed ID: 14685307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes.
    Mao J; Mukherjee S; Zhang Y; Cao R; Sanders JM; Song Y; Zhang Y; Meints GA; Gao YG; Mukkamala D; Hudock MP; Oldfield E
    J Am Chem Soc; 2006 Nov; 128(45):14485-97. PubMed ID: 17090032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase.
    Turek-Etienne TC; Strickland CL; Distefano MD
    Biochemistry; 2003 Apr; 42(13):3716-24. PubMed ID: 12667062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
    J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.
    Thompson K; Dunford JE; Ebetino FH; Rogers MJ
    Biochem Biophys Res Commun; 2002 Jan; 290(2):869-73. PubMed ID: 11785983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A crystallographic investigation of phosphoantigen binding to isopentenyl pyrophosphate/dimethylallyl pyrophosphate isomerase.
    Wouters J; Yin F; Song Y; Zhang Y; Oudjama Y; Stalon V; Droogmans L; Morita CT; Oldfield E
    J Am Chem Soc; 2005 Jan; 127(2):536-7. PubMed ID: 15643873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: structural variations around phosphonate anchor and spacer of fosmidomycin, a potent inhibitor of deoxyxylulose phosphate reductoisomerase.
    Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
    J Org Chem; 2010 May; 75(10):3203-7. PubMed ID: 20429517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
    Phaosiri C; Proteau PJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5309-12. PubMed ID: 15454217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of 1-deoxy-d-xylulose 5-phosphate reductoisomerase from the hyperthermophile Thermotoga maritima for insights into the coordination of conformational changes and an inhibitor binding.
    Takenoya M; Ohtaki A; Noguchi K; Endo K; Sasaki Y; Ohsawa K; Yajima S; Yohda M
    J Struct Biol; 2010 Jun; 170(3):532-9. PubMed ID: 20353826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.
    Sanders JM; Gómez AO; Mao J; Meints GA; Van Brussel EM; Burzynska A; Kafarski P; González-Pacanowska D; Oldfield E
    J Med Chem; 2003 Nov; 46(24):5171-83. PubMed ID: 14613320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies on Mycobacterium tuberculosis DXR in complex with the antibiotic FR-900098.
    Björkelid C; Bergfors T; Unge T; Mowbray SL; Jones TA
    Acta Crystallogr D Biol Crystallogr; 2012 Feb; 68(Pt 2):134-43. PubMed ID: 22281742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.